KR20030040258A - The increasing method of Vitamin D2 in mushroom - Google Patents
The increasing method of Vitamin D2 in mushroom Download PDFInfo
- Publication number
- KR20030040258A KR20030040258A KR1020030020909A KR20030020909A KR20030040258A KR 20030040258 A KR20030040258 A KR 20030040258A KR 1020030020909 A KR1020030020909 A KR 1020030020909A KR 20030020909 A KR20030020909 A KR 20030020909A KR 20030040258 A KR20030040258 A KR 20030040258A
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- mushroom
- content
- increasing
- mushrooms
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 5
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 title abstract description 25
- 229960002061 ergocalciferol Drugs 0.000 title abstract description 25
- 235000001892 vitamin D2 Nutrition 0.000 title abstract description 25
- 239000011653 vitamin D2 Substances 0.000 title abstract description 25
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 title abstract description 25
- 230000001678 irradiating effect Effects 0.000 claims abstract description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 22
- 229930003316 Vitamin D Natural products 0.000 claims description 21
- 235000019166 vitamin D Nutrition 0.000 claims description 21
- 239000011710 vitamin D Substances 0.000 claims description 21
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 20
- 229940046008 vitamin d Drugs 0.000 claims description 20
- 235000013399 edible fruits Nutrition 0.000 abstract description 15
- 240000000599 Lentinula edodes Species 0.000 abstract description 4
- 235000001603 Pleurotus ostreatus Nutrition 0.000 abstract description 4
- 240000001462 Pleurotus ostreatus Species 0.000 abstract description 4
- 238000003306 harvesting Methods 0.000 abstract description 4
- 241000222518 Agaricus Species 0.000 abstract 1
- 240000006499 Flammulina velutipes Species 0.000 abstract 1
- 235000016640 Flammulina velutipes Nutrition 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 11
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 244000252132 Pleurotus eryngii Species 0.000 description 4
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000002205 allergic conjunctivitis Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000020964 calcitriol Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- 229960005084 calcitriol Drugs 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 230000001201 calcium accumulation Effects 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- -1 vitamin A Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G18/00—Cultivation of mushrooms
- A01G18/80—Accessories for use after harvesting, e.g. scrapers
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G7/00—Botany in general
- A01G7/04—Electric or magnetic or acoustic treatment of plants for promoting growth
- A01G7/045—Electric or magnetic or acoustic treatment of plants for promoting growth with electric lighting
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Mycology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Botany (AREA)
- Ecology (AREA)
- Forests & Forestry (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
Description
[0001] [ 0001 ]
본 발명의 목적은, 버섯 자실체에 극히 소량 혹은 전혀 없는 비타민 D2의 함량을 자외선(UV) 등을 일정시간 조사하여 칼슘의 전구체인 비타민 D2의 함량이 높은 버섯을 생산하는 것을 그 목적으로 한다.An object of the present invention is to produce a mushroom having a high content of vitamin D2, which is a precursor of calcium, by irradiating UV (UV) for a predetermined time with a content of vitamin D2 which is extremely small or absent in the mushroom fruiting body.
[0002] [ 0002 ]
본 발명은 종래의 재배방법에는 전혀 없었던 자외선(UV) 등을 사용하는 방법으로, 자실체 수확 후에 일정한 높이와 시간 동안 자외선(UV) 등을 조사하여 버섯 자실체 내의 비타민 D2의 함량을 높이는 방법에 관한 것이다.The present invention relates to a method of using ultraviolet light (UV), which has not been found in the conventional cultivation method, and to increasing the content of vitamin D2 in the fruiting body of the mushroom by irradiating ultraviolet light (UV) for a predetermined height and time after fruiting body harvest. .
[0003] [ 0003 ]
현재까지 비타민 D는 provitamin D2에서 D7까지 발견되었다. 비타민 D는 자외선 조사로 비타민D2∼D7이 얻어지지만, 그 중에서 생물학적 활성이 높은 것은 D2와 D3뿐이다. 일반적으로 비타민D라고 부르는 것은 비타민D3를 말한다. 비타민D2는 식물성스테롤인 에르고스테롤에서,비타민D3는 동물성스테롤인 콜레스테롤에서 합성된다. 사람은 음식물에서 비타민D를 섭취할 뿐 아니라 체내에서 프로비타민D가 자외선에 의하여 비타민D로 전환되기도 한다.To date, vitamin D has been found from provitamin D2 to D7. Vitamin D is obtained by vitamin D2 to D7 by ultraviolet irradiation, of which only D2 and D3 have high biological activity. Commonly called vitamin D refers to vitamin D3. Vitamin D2 is synthesized from ergosterol, a vegetable sterol, and vitamin D3 from cholesterol, an animal sterol. In addition to vitamin D in humans, provitamin D is converted into vitamin D by UV light.
전환율은 나이에 따라 차이가 있는데 유아에서는 0.15%, 성인에서는 0.43%정도이다. 섭취된 비타민D는 간장에 가장 많이 저장되고 다음으로 피부, 폐, 비장, 뇌, 뼈 등에도 저장된다. 비타민A의 경우는 대부분 간장에 저장되지만 비타민D는 체내의 전체 기관에 저장된다. 또한 다량 섭취 시에는 대변과 소변으로 배설된다. 프로비타민D에서 비타민D로 전환되는 경우 자외선의 파장(270∼300nm)은 한정되어 있기 때문에 보통의 유리창문을 통한 광선은 비타민D의 생성에 유효하지 못하다. 비타민D는 비타민A와 같이 광선이나 산소에 의해 분해되므로 식품의 가공에 의해 그 함량은 감소한다.Conversion rates vary with age, with 0.15% in infants and 0.43% in adults. Ingested vitamin D is most commonly stored in the liver, followed by the skin, lungs, spleen, brain and bones. Most vitamin A is stored in the liver, but vitamin D is stored in all the organs of the body. In addition, large amounts are excreted in feces and urine. In the case of conversion from provitamin D to vitamin D, the wavelength of ultraviolet rays (270-300 nm) is limited, so light rays through ordinary glass windows are not effective for the production of vitamin D. Vitamin D, like vitamin A, is broken down by light and oxygen, so its content is reduced by food processing.
[0004] [ 0004 ]
비타민 D의 효과는 다음과 같다.Vitamin D has the following effects:
(1)칼슘과 인의 흡수를 촉진, 조직 중의 인산을 칼슘과 결합시켜 뼈에 침착시킨다.(1) It promotes the absorption of calcium and phosphorus and binds phosphoric acid in tissues to calcium and deposits it on bone.
(2)혈액 중의 칼슘축적을 조정하는 부갑상선의 기능을 원만하게 해 주고, 갑상선의 기능도 건전하게 해 준다.(2) It smoothes the function of the parathyroid gland to adjust the calcium accumulation in the blood, and also makes the function of the thyroid gland sound.
(3)구루병, 충치, 골절의 예방(3) prevention of rickets, caries, fractures
(4)골다공증과 골연화증을 치료. 치아건강에 필수적:치조농루,성장기 어린이의 치아와 뼈 형성을 돕는다.(4) Treating osteoporosis and osteomalacia. Essential for dental health: Helps to form teeth and bones in children with alveolar pustules and growing children.
(5)생식기능을 나타낸다.(5) It shows reproductive function.
(6)면역증강작용:결핵치료를 촉진(6) Immune enhancing effect: promote tuberculosis treatment
(7)유전자 조절 기능:해당세포의 핵에 들어가 RNA합성을 활성화시킨다.(7) Gene regulation function: enters the nucleus of the cell and activates RNA synthesis.
(8)건선에 유효하다. 피부세포에는 VIT.D receptor가 존재한다.(8) It is effective for psoriasis. Skin cells contain the VIT.D receptor.
(9)세포분열을 촉진한다.(9) Promote cell division.
(10)암예방에 효과가 있다.(10) It is effective in cancer prevention.
(11)calcitriol은 백혈병, 유방암,melanoma,림프암,대장암의 성장을 억제한다.(11) calcitriol inhibits the growth of leukemia, breast cancer, melanoma, lymph cancer, and colon cancer.
(12)비타민A와 함께 감기를 억제한다.(12) It suppresses a cold with vitamin A.
(13)식이중 비타민D가 부족하면 위산부족이 된다.(13) Lack of vitamin D in the diet is a lack of stomach acid.
(14)비타민D 5만단위+칼슘1g을 투여하여 근시가 개선되었다.(14) Myopia was improved by administering 50,000 D of vitamin D + 1 g of calcium.
(15)5만 단위의 비타민D를 7주간 투여하여 알러지성 결막염이 개선되었다.(15) Allergic conjunctivitis was improved by administering 50,000 units of vitamin D for 7 weeks.
(16)A와 D를 동시에 투여한 그룹에서 80%가 감기횟수가 감소 또는 개선되었다.(16) In the group treated with A and D at the same time, the number of colds was reduced or improved by 80%.
(17)혈압 조절에 관여 가능성(칼슘 대사를 통하여)(17) possibility of blood pressure regulation (through calcium metabolism)
(18)결장암 및 유방암 예방(18) Colon cancer and breast cancer prevention
(19)비타민D의 공급이 충분하지 않으면 인체는 정상적으로 인슐린을 분비할 수 없으며 당대사도 적절히 수행할 수 없다. 그러나 불행히도 많은 노인들은 햇볕을 쬐거나 또는 식사를 통해서도 비타민D를 충분히 얻지 못하고 있으며, 이는 노인들에게서 당뇨 위험이 더욱 높아질 수 있음을 시사한다.(19) Without enough vitamin D, the human body cannot secrete insulin normally, and its metabolism cannot be properly performed. Unfortunately, many older people do not get enough vitamin D from sunburn or eating, suggesting a higher risk of diabetes in older people.
비타민 D의 1일 권장량은 400IU이다.The recommended daily dose of vitamin D is 400 IU.
[0005] [ 0005 ]
버섯은 인체에 매우 유익한 것이지만, 인체에 꼭필요한 비타민 D2의 함량은 매우 적은 것이 사실이다. 본 발명은 수확 후에 자외선(UV) 등을 일정 거리에서 일정시간 조사함으로써 비타민 D2를 다량 함유한 버섯 자실체를 얻는 것을 방법의 개발을 과제로 한다.Although mushrooms are very beneficial to the human body, it is true that vitamin D2 content is essential for the human body. An object of the present invention is to obtain a mushroom fruiting body containing a large amount of vitamin D2 by irradiating UV (UV) light at a predetermined distance after harvesting.
[0006] [ 0006 ]
본 발명은, 버섯 자실체의 수확하여 자외선(UV)등을 20CM 높이에서 30초간 조사하여 기존 버섯의 함유하는 비타민 D2의 함량을 최소 2배에서 1000배 이상으로 증량시키는 것이다.The present invention, by harvesting the fruiting body of the mushroom and irradiated with ultraviolet (UV) for 30 seconds at a height of 20CM to increase the content of vitamin D2 containing the existing mushroom to at least 2 times to 1000 times or more.
[0007] [ 0007 ]
본 발명은 비용 상승이 거의 없이 비타민 D2의 함량을 증가시키는 것이다.The present invention is to increase the content of vitamin D2 with little cost increase.
[0008] [ 0008 ]
[실시예 및 비교예] [Examples and Comparative Examples;
이하 실시예를 나타내어, 더욱 구체적으로 설명한다. 또, 본 발명은, 이하의 실시예에 한정되어 있는 것은 아니다.An Example is shown below and it demonstrates more concretely. In addition, this invention is not limited to the following example.
비교예1) 자외선 조사시간에 따른 양송이 자실체의 비타민 D2 함량의 변화Comparative Example 1 Changes in Vitamin D2 Contents of Fruiting Fruits in the Fruits with Ultraviolet Irradiation Time
비교예1-1) 자외선 조사 높이에 따른 양송이 자실체의 비타민 D2 함량의 변화Comparative Example 1-1) Changes in Vitamin D2 Contents of Fruiting Fruits in Different Fruits
비교예2) 자외선 조사시간에 따른 표고버섯 자실체의 비타민 D2 함량의 변화Comparative Example 2) Changes in Vitamin D2 Content of Shiitake Mushroom Fruits with Ultraviolet Irradiation Time
비교예2-1) 자외선 조사 높이에 따른 표고버섯 자실체의 비타민 D2 함량의 변화Comparative Example 2-1) Changes in Vitamin D2 Content of Shiitake Fruiting Fruits According to UV Irradiation Height
비교예3) 자외선 조사시간에 따른 팽이버섯 자실체의 비타민 D2 함량의 변화Comparative Example 3) Changes in Vitamin D2 Content of Enoki Mushroom Fruits with Ultraviolet Irradiation Time
비교예3-1) 자외선 조사 높이에 따른 팽이버섯 자실체의 비타민 D2 함량의 변화Comparative Example 3-1) Changes in Vitamin D2 Content of Enoki Mushroom Fruits According to UV Irradiation Height
비교예4) 자외선 조사시간에 따른 새송이버섯 자실체의 비타민 D2 함량의 변화Comparative Example 4 Changes of Vitamin D2 Contents of the Fruits of Pleurotus eryngii with Ultraviolet Irradiation Time
비교예4-1) 자외선 조사 높이에 따른 새송이버섯 자실체의 비타민 D2 함량의 변화Comparative Example 4-1) Changes in Vitamin D2 Content of Pleurotus eryngii Fruits According to UV Irradiation Height
비교예5) 자외선 조사시간에 따른 느타리버섯 자실체의 비타민 D2 함량의 변화Comparative Example 5 Variation of Vitamin D2 Content of Pleurotus eryngii Fruits According to UV Irradiation Time
비교예5-1) 자외선 조사 높이에 따른 느타리버섯 자실체의 비타민 D2 함량의 변화Comparative Example 5-1) Changes in Vitamin D2 Content of Pleurotus eryngii Fruits According to UV Irradiation Height
[0009] [ 0009 ]
본 발명에 의해서 현재까지 비타민 D2의 함량이 매우 적었던 식용 및 약용버섯에 자외선 조사를 통해 표고버섯은 2.44배, 팽이버섯은 7.5배, 양송이버섯은 1349배, 새송이버섯은 52배, 느타리버섯은 2.1배의 비타민 D2를 증가시킨 버섯을함으로써 고부가가치 및 차별화된 버섯의 공급이 가능한 것이다.According to the present invention, shiitake mushrooms were 2.44 times, oyster mushrooms 7.5 times, mushroom mushrooms 1349 times, oyster mushrooms 52 times, and oyster mushrooms through ultraviolet irradiation to edible and medicinal mushrooms that had a very low content of vitamin D2. By adding 2.1 times more vitamin D2, mushrooms will be able to supply high value and differentiated mushrooms.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030020909A KR20030040258A (en) | 2003-04-02 | 2003-04-02 | The increasing method of Vitamin D2 in mushroom |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030020909A KR20030040258A (en) | 2003-04-02 | 2003-04-02 | The increasing method of Vitamin D2 in mushroom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20030040258A true KR20030040258A (en) | 2003-05-22 |
Family
ID=29579149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020030020909A KR20030040258A (en) | 2003-04-02 | 2003-04-02 | The increasing method of Vitamin D2 in mushroom |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20030040258A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011035314A3 (en) * | 2009-09-21 | 2011-08-04 | Total Nutraceutical Solutions, Inc. | Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states |
| US8545915B2 (en) | 2008-05-02 | 2013-10-01 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| US9326540B2 (en) | 2012-09-27 | 2016-05-03 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| US10930342B2 (en) | 2012-09-27 | 2021-02-23 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| KR20210100483A (en) * | 2020-02-06 | 2021-08-17 | 김정옥 | Method for preparation of vitamin D2 from Lentinus edodes mushroom |
| US12022850B2 (en) | 2020-02-06 | 2024-07-02 | Jeong Ok Kim | Method for preparing vitamin D derived from shiitake mushrooms |
-
2003
- 2003-04-02 KR KR1020030020909A patent/KR20030040258A/en not_active Application Discontinuation
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8545915B2 (en) | 2008-05-02 | 2013-10-01 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| WO2011035314A3 (en) * | 2009-09-21 | 2011-08-04 | Total Nutraceutical Solutions, Inc. | Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states |
| US9326540B2 (en) | 2012-09-27 | 2016-05-03 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| US10930342B2 (en) | 2012-09-27 | 2021-02-23 | Oakshire Holdings, Inc. | Method and apparatus for vitamin D enhancement in mushrooms |
| KR20210100483A (en) * | 2020-02-06 | 2021-08-17 | 김정옥 | Method for preparation of vitamin D2 from Lentinus edodes mushroom |
| US12022850B2 (en) | 2020-02-06 | 2024-07-02 | Jeong Ok Kim | Method for preparing vitamin D derived from shiitake mushrooms |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1045162C (en) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| CA2861651A1 (en) | A nutritional approach to the use of ergothioneine and vitamin d2 for hair, nail and skin growth | |
| CN106666024A (en) | Vitamin D2-rich natural bacterium powder tablet candy and preparation method thereof | |
| CN1947600A (en) | Sun-rays proof beauty-care beverage | |
| US20090053324A1 (en) | Calcium supplements | |
| CN110151715B (en) | Calcium chewable tablet suitable for lactating women and preparation method thereof | |
| KR20030040258A (en) | The increasing method of Vitamin D2 in mushroom | |
| Al-Azzawi et al. | A Comprehensive Review of Vitamin D3: Metabolism, Functions, and Clinical Implications | |
| Jenabi et al. | Vitamin D toxicity; Stored and released from adipose tissue? | |
| JP7273763B2 (en) | Natural hot spring concentrate and its production method | |
| KR100468337B1 (en) | Korean traditional soy sauces fortified with vitamin D and preparation thereof | |
| CN101091720A (en) | Health food with efficacy for preventing osteoporosis and preparation method | |
| CN101167493A (en) | Dairy product containing rich coenzyme Q10 and preparation method thereof | |
| CN1204057C (en) | Multielement mineral water and its preparation method and application | |
| JPH08205819A (en) | Beverage for health | |
| Aydın et al. | Vitamin D and Dentistry | |
| EP4101291A1 (en) | Method for preparing vitamin d derived from shiitake mushrooms | |
| Szabó et al. | The effect of UV light on the Vitamin D content and mycelial growth of oyster mushroom | |
| Chaudhary et al. | Status of Vitamin D and its correlation with Diabetes in North Gujarat, India: https://doi. org/10.54037/WJPS. 2021.91206 | |
| KR20040052747A (en) | Method for cultivating strawberry containing selenium | |
| MK et al. | Evaluation Of Pleurotus Florida (White Oyster Mushroom) Cultivated In Amalaki Medium In The Management Of Vitamin D Deficiency | |
| Saidullaeva et al. | THE ROLE OF VEGETABLES IN THE SPREAD AND PREVENTION OF TUMOR DISEASES | |
| US12022850B2 (en) | Method for preparing vitamin D derived from shiitake mushrooms | |
| CN102302147A (en) | Polypeptide beverage for neutralizing and dispelling effect of alcoholic drinks | |
| Lanham-New | Vitamin D in the spotlight–time for urgent action? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| N231 | Notification of change of applicant | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |